Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

Part of paid clinical trials in Fort Smith, Arkansas.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT03935282
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AH-HA Tool in the EPIC EHR — OTHER
    The Automated Heart-Health Assessment tool implemented in clinics' EPIC EHR will be used by providers during routine follow-up care appointments.

Study Details

The objective of this hybrid effectiveness-implementation study is to examine the effects of an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate, colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600) receiving survivorship care in community oncology practices, using a group-randomized trial design (6 intervention practices and 6 usual care practices). Our central hypothesis is that the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and oncology providers, (2) referrals and visits to primary care and cardiology (care coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities compared to usual care.

Key Dates

Start date
Oct 1, 2020
Status verified
Mar 2026
Primary completion
Mar 7, 2025
Completion
Nov 17, 2025

Study Design

Enrollment
645 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Intervention - AH-HA tool
    With assistance from the study team, the clinic will implement the AH-HA tool in the clinics' EPIC EHR. Providers at the intervention sites will be trained to use the tool during routine follow-up care with survivors. During a routine follow-up care appointment, the provider will use the AH-HA tool with enrolled patients.
  • No Intervention: Usual Care
    Usual care practices will conduct routine follow-up care visits for enrolled survivors following typical clinic practice, without use of the AH-HA tool.

Primary Outcome Measure

Proportion of Patients Reporting Discussion of at Least One Non-ideal or Missing CVH Topic [ Time Frame: Baseline ]

Locations (12)

FacilityCityStateZIPSite coordinators
Mercy Hospital Fort SmithFort SmithArkansas72903-
Oncology Associates at Mercy Medical CenterCedar RapidsIowa52403-
Saint Louis Cancer and Breast Institute-BallwinBallwinMissouri63011-
Mercy Hospital SpringfieldSpringfieldMissouri65804-
Mercy Hospital Saint LouisSt LouisMissouri63141-
Mercy Hospital Oklahoma CityOklahoma CityOklahoma73120-
Community Medical CenterScrantonPennsylvania18510-
Geisinger Wyoming Valley/Henry Cancer CenterWilkes-BarrePennsylvania18711-
Baptist Memorial Hospital and Cancer Center-MemphisMemphisTennessee38120-
Baptist Memorial Hospital for WomenMemphisTennessee38120-
Virginia Commonwealth University/Massey Cancer CenterRichmondVirginia23298-
ThedaCare Regional Cancer CenterAppletonWisconsin54911-

Find similar trials in Fort Smith, AR

By condition
Breast cancerColorectal cancer
By specialty
OncologyBreast oncologyWomen's healthGI oncology
By research site
Mercy Hospital Fort Smith· Fort Smith, AROncology Associates at Mercy Medical Center· Cedar Rapids, IASaint Louis Cancer and Breast Institute-Ballwin· Ballwin, MOMercy Hospital Springfield· Springfield, MOMercy Hospital Saint Louis· St Louis, MOMercy Hospital Oklahoma City· Oklahoma City, OK

Related Studies